Novoheart created a first with its artificial “mini-hearts” which can contract and mimic the fluid-pumping action of a natural heart. Photo: Winson Wong
Hong Kong scientist behind artificial ‘mini-hearts’ takes Novoheart closer to China with facilities to quicken drug discovery process
- Company behind ‘mini-hearts’ innovation sets up laboratory in Hong Kong to get closer to talents and access to markets
- Hong Kong scientist is taking Canada-listed Novoheart private, does not rule out tapping local capital market for funds
Novoheart created a first with its artificial “mini-hearts” which can contract and mimic the fluid-pumping action of a natural heart. Photo: Winson Wong
